nodes	percent_of_prediction	percent_of_DWPC	metapath
Tapentadol—UGT1A9—Mycophenolate mofetil—systemic lupus erythematosus	0.205	0.289	CbGbCtD
Tapentadol—UGT2B7—Mycophenolate mofetil—systemic lupus erythematosus	0.194	0.274	CbGbCtD
Tapentadol—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0555	0.0783	CbGbCtD
Tapentadol—CYP2C19—Dapsone—systemic lupus erythematosus	0.0476	0.0671	CbGbCtD
Tapentadol—CYP2C9—Dapsone—systemic lupus erythematosus	0.0396	0.0558	CbGbCtD
Tapentadol—CYP2C19—Prednisone—systemic lupus erythematosus	0.033	0.0465	CbGbCtD
Tapentadol—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0313	0.0441	CbGbCtD
Tapentadol—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.026	0.0366	CbGbCtD
Tapentadol—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0238	0.0335	CbGbCtD
Tapentadol—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.0206	0.029	CbGbCtD
Tapentadol—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0171	0.0241	CbGbCtD
Tapentadol—CYP2C9—cardial valve—systemic lupus erythematosus	0.016	0.27	CbGeAlD
Tapentadol—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.0157	0.0221	CbGbCtD
Tapentadol—CYP2C19—urine—systemic lupus erythematosus	0.00446	0.0751	CbGeAlD
Tapentadol—CYP2C9—urine—systemic lupus erythematosus	0.00346	0.0582	CbGeAlD
Tapentadol—UGT1A9—kidney—systemic lupus erythematosus	0.00284	0.0478	CbGeAlD
Tapentadol—SLC6A4—blood plasma—systemic lupus erythematosus	0.00281	0.0473	CbGeAlD
Tapentadol—CYP2D6—urine—systemic lupus erythematosus	0.00259	0.0437	CbGeAlD
Tapentadol—CYP2C19—blood plasma—systemic lupus erythematosus	0.00233	0.0392	CbGeAlD
Tapentadol—UGT2B7—kidney—systemic lupus erythematosus	0.00229	0.0386	CbGeAlD
Tapentadol—OPRD1—kidney—systemic lupus erythematosus	0.00224	0.0378	CbGeAlD
Tapentadol—CYP2C9—blood plasma—systemic lupus erythematosus	0.0018	0.0304	CbGeAlD
Tapentadol—OPRD1—nervous system—systemic lupus erythematosus	0.00147	0.0248	CbGeAlD
Tapentadol—OPRD1—central nervous system—systemic lupus erythematosus	0.00142	0.0239	CbGeAlD
Tapentadol—OPRK1—nervous system—systemic lupus erythematosus	0.00141	0.0238	CbGeAlD
Tapentadol—OPRK1—central nervous system—systemic lupus erythematosus	0.00136	0.0229	CbGeAlD
Tapentadol—CYP2D6—blood plasma—systemic lupus erythematosus	0.00135	0.0228	CbGeAlD
Tapentadol—HTR3A—lung—systemic lupus erythematosus	0.00118	0.0199	CbGeAlD
Tapentadol—HTR3A—nervous system—systemic lupus erythematosus	0.00109	0.0185	CbGeAlD
Tapentadol—HTR3A—central nervous system—systemic lupus erythematosus	0.00105	0.0178	CbGeAlD
Tapentadol—OPRM1—nervous system—systemic lupus erythematosus	0.001	0.0169	CbGeAlD
Tapentadol—OPRM1—central nervous system—systemic lupus erythematosus	0.000966	0.0163	CbGeAlD
Tapentadol—SLC6A4—lung—systemic lupus erythematosus	0.000902	0.0152	CbGeAlD
Tapentadol—SLC6A4—nervous system—systemic lupus erythematosus	0.000835	0.0141	CbGeAlD
Tapentadol—SLC6A4—central nervous system—systemic lupus erythematosus	0.000804	0.0135	CbGeAlD
Tapentadol—SLC6A2—lung—systemic lupus erythematosus	0.000794	0.0134	CbGeAlD
Tapentadol—SLC6A2—nervous system—systemic lupus erythematosus	0.000735	0.0124	CbGeAlD
Tapentadol—SLC6A2—central nervous system—systemic lupus erythematosus	0.000708	0.0119	CbGeAlD
Tapentadol—CYP2D6—kidney—systemic lupus erythematosus	0.000613	0.0103	CbGeAlD
Tapentadol—CYP2D6—nervous system—systemic lupus erythematosus	0.000402	0.00678	CbGeAlD
Tapentadol—CYP2D6—central nervous system—systemic lupus erythematosus	0.000387	0.00653	CbGeAlD
Tapentadol—Syncope—Dexamethasone—systemic lupus erythematosus	0.000267	0.00118	CcSEcCtD
Tapentadol—Syncope—Betamethasone—systemic lupus erythematosus	0.000267	0.00118	CcSEcCtD
Tapentadol—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000267	0.00118	CcSEcCtD
Tapentadol—Infection—Triamcinolone—systemic lupus erythematosus	0.000266	0.00117	CcSEcCtD
Tapentadol—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.000266	0.00117	CcSEcCtD
Tapentadol—Infection—Methylprednisolone—systemic lupus erythematosus	0.000265	0.00117	CcSEcCtD
Tapentadol—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000263	0.00116	CcSEcCtD
Tapentadol—Vomiting—Leflunomide—systemic lupus erythematosus	0.000263	0.00116	CcSEcCtD
Tapentadol—Shock—Triamcinolone—systemic lupus erythematosus	0.000263	0.00116	CcSEcCtD
Tapentadol—Insomnia—Prednisolone—systemic lupus erythematosus	0.000263	0.00116	CcSEcCtD
Tapentadol—Shock—Methylprednisolone—systemic lupus erythematosus	0.000263	0.00116	CcSEcCtD
Tapentadol—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000262	0.00115	CcSEcCtD
Tapentadol—Loss of consciousness—Betamethasone—systemic lupus erythematosus	0.000261	0.00115	CcSEcCtD
Tapentadol—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	0.000261	0.00115	CcSEcCtD
Tapentadol—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000261	0.00115	CcSEcCtD
Tapentadol—Rash—Leflunomide—systemic lupus erythematosus	0.000261	0.00115	CcSEcCtD
Tapentadol—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000261	0.00115	CcSEcCtD
Tapentadol—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000261	0.00115	CcSEcCtD
Tapentadol—Mental disorder—Prednisone—systemic lupus erythematosus	0.000261	0.00115	CcSEcCtD
Tapentadol—Nausea—Azathioprine—systemic lupus erythematosus	0.000261	0.00115	CcSEcCtD
Tapentadol—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000261	0.00115	CcSEcCtD
Tapentadol—Headache—Leflunomide—systemic lupus erythematosus	0.00026	0.00114	CcSEcCtD
Tapentadol—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000259	0.00114	CcSEcCtD
Tapentadol—Malnutrition—Prednisone—systemic lupus erythematosus	0.000259	0.00114	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000259	0.00114	CcSEcCtD
Tapentadol—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000259	0.00114	CcSEcCtD
Tapentadol—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.000258	0.00114	CcSEcCtD
Tapentadol—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000258	0.00114	CcSEcCtD
Tapentadol—Convulsion—Betamethasone—systemic lupus erythematosus	0.000258	0.00114	CcSEcCtD
Tapentadol—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000257	0.00113	CcSEcCtD
Tapentadol—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000257	0.00113	CcSEcCtD
Tapentadol—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000255	0.00112	CcSEcCtD
Tapentadol—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000254	0.00112	CcSEcCtD
Tapentadol—Anxiety—Betamethasone—systemic lupus erythematosus	0.000252	0.00111	CcSEcCtD
Tapentadol—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000252	0.00111	CcSEcCtD
Tapentadol—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.00025	0.0011	CcSEcCtD
Tapentadol—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000249	0.0011	CcSEcCtD
Tapentadol—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000248	0.00109	CcSEcCtD
Tapentadol—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000247	0.00109	CcSEcCtD
Tapentadol—Nausea—Leflunomide—systemic lupus erythematosus	0.000246	0.00108	CcSEcCtD
Tapentadol—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000246	0.00108	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000245	0.00108	CcSEcCtD
Tapentadol—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000245	0.00108	CcSEcCtD
Tapentadol—Vision blurred—Prednisone—systemic lupus erythematosus	0.000244	0.00108	CcSEcCtD
Tapentadol—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000244	0.00107	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000244	0.00107	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000243	0.00107	CcSEcCtD
Tapentadol—Oedema—Betamethasone—systemic lupus erythematosus	0.000243	0.00107	CcSEcCtD
Tapentadol—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000243	0.00107	CcSEcCtD
Tapentadol—Oedema—Dexamethasone—systemic lupus erythematosus	0.000243	0.00107	CcSEcCtD
Tapentadol—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000243	0.00107	CcSEcCtD
Tapentadol—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000242	0.00107	CcSEcCtD
Tapentadol—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000241	0.00106	CcSEcCtD
Tapentadol—Infection—Dexamethasone—systemic lupus erythematosus	0.000241	0.00106	CcSEcCtD
Tapentadol—Infection—Betamethasone—systemic lupus erythematosus	0.000241	0.00106	CcSEcCtD
Tapentadol—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.00024	0.00106	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.00024	0.00106	CcSEcCtD
Tapentadol—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.00024	0.00106	CcSEcCtD
Tapentadol—Visual impairment—Methotrexate—systemic lupus erythematosus	0.00024	0.00106	CcSEcCtD
Tapentadol—Shock—Betamethasone—systemic lupus erythematosus	0.000239	0.00105	CcSEcCtD
Tapentadol—Shock—Dexamethasone—systemic lupus erythematosus	0.000239	0.00105	CcSEcCtD
Tapentadol—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000239	0.00105	CcSEcCtD
Tapentadol—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000238	0.00105	CcSEcCtD
Tapentadol—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000238	0.00105	CcSEcCtD
Tapentadol—Agitation—Prednisone—systemic lupus erythematosus	0.000238	0.00105	CcSEcCtD
Tapentadol—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000237	0.00104	CcSEcCtD
Tapentadol—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000237	0.00104	CcSEcCtD
Tapentadol—Angioedema—Prednisone—systemic lupus erythematosus	0.000237	0.00104	CcSEcCtD
Tapentadol—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000236	0.00104	CcSEcCtD
Tapentadol—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000236	0.00104	CcSEcCtD
Tapentadol—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000235	0.00104	CcSEcCtD
Tapentadol—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000235	0.00103	CcSEcCtD
Tapentadol—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000235	0.00103	CcSEcCtD
Tapentadol—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000234	0.00103	CcSEcCtD
Tapentadol—Vertigo—Prednisone—systemic lupus erythematosus	0.000233	0.00103	CcSEcCtD
Tapentadol—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000232	0.00102	CcSEcCtD
Tapentadol—Syncope—Prednisone—systemic lupus erythematosus	0.000232	0.00102	CcSEcCtD
Tapentadol—Urticaria—Prednisolone—systemic lupus erythematosus	0.000231	0.00102	CcSEcCtD
Tapentadol—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000231	0.00102	CcSEcCtD
Tapentadol—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000231	0.00102	CcSEcCtD
Tapentadol—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.00023	0.00101	CcSEcCtD
Tapentadol—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.00023	0.00101	CcSEcCtD
Tapentadol—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000229	0.00101	CcSEcCtD
Tapentadol—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000228	0.001	CcSEcCtD
Tapentadol—Hypotension—Betamethasone—systemic lupus erythematosus	0.000227	0.001	CcSEcCtD
Tapentadol—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000227	0.001	CcSEcCtD
Tapentadol—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000226	0.000997	CcSEcCtD
Tapentadol—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000226	0.000995	CcSEcCtD
Tapentadol—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000226	0.000995	CcSEcCtD
Tapentadol—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000225	0.00099	CcSEcCtD
Tapentadol—Convulsion—Prednisone—systemic lupus erythematosus	0.000224	0.00099	CcSEcCtD
Tapentadol—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000224	0.000988	CcSEcCtD
Tapentadol—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000224	0.000987	CcSEcCtD
Tapentadol—Chills—Methotrexate—systemic lupus erythematosus	0.000223	0.000984	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000221	0.000975	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000221	0.000975	CcSEcCtD
Tapentadol—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000221	0.000973	CcSEcCtD
Tapentadol—Arthralgia—Prednisone—systemic lupus erythematosus	0.000221	0.000972	CcSEcCtD
Tapentadol—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.00022	0.000972	CcSEcCtD
Tapentadol—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.00022	0.00097	CcSEcCtD
Tapentadol—Anxiety—Prednisone—systemic lupus erythematosus	0.00022	0.000969	CcSEcCtD
Tapentadol—Insomnia—Betamethasone—systemic lupus erythematosus	0.00022	0.000968	CcSEcCtD
Tapentadol—Insomnia—Dexamethasone—systemic lupus erythematosus	0.00022	0.000968	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000219	0.000966	CcSEcCtD
Tapentadol—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000219	0.000965	CcSEcCtD
Tapentadol—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000218	0.000961	CcSEcCtD
Tapentadol—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000218	0.000961	CcSEcCtD
Tapentadol—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000218	0.000961	CcSEcCtD
Tapentadol—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000216	0.000955	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000214	0.000945	CcSEcCtD
Tapentadol—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000214	0.000942	CcSEcCtD
Tapentadol—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000214	0.000942	CcSEcCtD
Tapentadol—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000213	0.000941	CcSEcCtD
Tapentadol—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000213	0.000937	CcSEcCtD
Tapentadol—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000212	0.000935	CcSEcCtD
Tapentadol—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000211	0.000932	CcSEcCtD
Tapentadol—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000211	0.000932	CcSEcCtD
Tapentadol—Oedema—Prednisone—systemic lupus erythematosus	0.000211	0.000932	CcSEcCtD
Tapentadol—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000211	0.00093	CcSEcCtD
Tapentadol—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000211	0.00093	CcSEcCtD
Tapentadol—Infection—Prednisone—systemic lupus erythematosus	0.00021	0.000926	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.00021	0.000924	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.00021	0.000924	CcSEcCtD
Tapentadol—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000209	0.000923	CcSEcCtD
Tapentadol—Fatigue—Betamethasone—systemic lupus erythematosus	0.000209	0.000923	CcSEcCtD
Tapentadol—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000209	0.000923	CcSEcCtD
Tapentadol—Shock—Prednisone—systemic lupus erythematosus	0.000208	0.000917	CcSEcCtD
Tapentadol—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000207	0.000914	CcSEcCtD
Tapentadol—Tachycardia—Prednisone—systemic lupus erythematosus	0.000206	0.00091	CcSEcCtD
Tapentadol—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000206	0.000909	CcSEcCtD
Tapentadol—Skin disorder—Prednisone—systemic lupus erythematosus	0.000205	0.000905	CcSEcCtD
Tapentadol—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000204	0.000901	CcSEcCtD
Tapentadol—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000204	0.0009	CcSEcCtD
Tapentadol—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000204	0.000899	CcSEcCtD
Tapentadol—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000203	0.000896	CcSEcCtD
Tapentadol—Rash—Cyclosporine—systemic lupus erythematosus	0.000202	0.000889	CcSEcCtD
Tapentadol—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000201	0.000888	CcSEcCtD
Tapentadol—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000201	0.000886	CcSEcCtD
Tapentadol—Headache—Cyclosporine—systemic lupus erythematosus	0.0002	0.000883	CcSEcCtD
Tapentadol—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.0002	0.000882	CcSEcCtD
Tapentadol—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.0002	0.000882	CcSEcCtD
Tapentadol—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000198	0.000874	CcSEcCtD
Tapentadol—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000197	0.000869	CcSEcCtD
Tapentadol—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000197	0.000867	CcSEcCtD
Tapentadol—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000197	0.000867	CcSEcCtD
Tapentadol—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000196	0.000866	CcSEcCtD
Tapentadol—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000195	0.000862	CcSEcCtD
Tapentadol—Vertigo—Methotrexate—systemic lupus erythematosus	0.000194	0.000858	CcSEcCtD
Tapentadol—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000194	0.000857	CcSEcCtD
Tapentadol—Urticaria—Betamethasone—systemic lupus erythematosus	0.000193	0.00085	CcSEcCtD
Tapentadol—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000193	0.00085	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000193	0.000849	CcSEcCtD
Tapentadol—Dizziness—Prednisolone—systemic lupus erythematosus	0.000192	0.000848	CcSEcCtD
Tapentadol—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000192	0.000846	CcSEcCtD
Tapentadol—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000192	0.000845	CcSEcCtD
Tapentadol—Insomnia—Prednisone—systemic lupus erythematosus	0.000191	0.000843	CcSEcCtD
Tapentadol—Nausea—Cyclosporine—systemic lupus erythematosus	0.00019	0.000837	CcSEcCtD
Tapentadol—Paraesthesia—Prednisone—systemic lupus erythematosus	0.00019	0.000837	CcSEcCtD
Tapentadol—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000189	0.000835	CcSEcCtD
Tapentadol—Cough—Methotrexate—systemic lupus erythematosus	0.000189	0.000833	CcSEcCtD
Tapentadol—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000189	0.000833	CcSEcCtD
Tapentadol—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000188	0.000828	CcSEcCtD
Tapentadol—Convulsion—Methotrexate—systemic lupus erythematosus	0.000188	0.000827	CcSEcCtD
Tapentadol—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000186	0.000821	CcSEcCtD
Tapentadol—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000185	0.000817	CcSEcCtD
Tapentadol—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000184	0.000813	CcSEcCtD
Tapentadol—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000184	0.00081	CcSEcCtD
Tapentadol—Rash—Prednisolone—systemic lupus erythematosus	0.000183	0.000809	CcSEcCtD
Tapentadol—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000183	0.000808	CcSEcCtD
Tapentadol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000183	0.000807	CcSEcCtD
Tapentadol—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000183	0.000805	CcSEcCtD
Tapentadol—Fatigue—Prednisone—systemic lupus erythematosus	0.000182	0.000804	CcSEcCtD
Tapentadol—Headache—Prednisolone—systemic lupus erythematosus	0.000182	0.000804	CcSEcCtD
Tapentadol—Constipation—Prednisone—systemic lupus erythematosus	0.000181	0.000797	CcSEcCtD
Tapentadol—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000181	0.000797	CcSEcCtD
Tapentadol—Rash—Hydrocortisone—systemic lupus erythematosus	0.000179	0.00079	CcSEcCtD
Tapentadol—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000179	0.000789	CcSEcCtD
Tapentadol—Confusional state—Methotrexate—systemic lupus erythematosus	0.000178	0.000786	CcSEcCtD
Tapentadol—Headache—Hydrocortisone—systemic lupus erythematosus	0.000178	0.000785	CcSEcCtD
Tapentadol—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000177	0.00078	CcSEcCtD
Tapentadol—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000177	0.000779	CcSEcCtD
Tapentadol—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000177	0.000778	CcSEcCtD
Tapentadol—Infection—Methotrexate—systemic lupus erythematosus	0.000176	0.000774	CcSEcCtD
Tapentadol—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000174	0.000768	CcSEcCtD
Tapentadol—Asthenia—Betamethasone—systemic lupus erythematosus	0.000174	0.000768	CcSEcCtD
Tapentadol—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000174	0.000768	CcSEcCtD
Tapentadol—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000173	0.000764	CcSEcCtD
Tapentadol—Nausea—Prednisolone—systemic lupus erythematosus	0.000173	0.000762	CcSEcCtD
Tapentadol—Pruritus—Betamethasone—systemic lupus erythematosus	0.000172	0.000757	CcSEcCtD
Tapentadol—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000172	0.000757	CcSEcCtD
Tapentadol—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000172	0.000757	CcSEcCtD
Tapentadol—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000171	0.000753	CcSEcCtD
Tapentadol—Vomiting—Triamcinolone—systemic lupus erythematosus	0.00017	0.00075	CcSEcCtD
Tapentadol—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.00017	0.000748	CcSEcCtD
Tapentadol—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000169	0.000744	CcSEcCtD
Tapentadol—Rash—Triamcinolone—systemic lupus erythematosus	0.000169	0.000744	CcSEcCtD
Tapentadol—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000169	0.000743	CcSEcCtD
Tapentadol—Rash—Methylprednisolone—systemic lupus erythematosus	0.000168	0.000742	CcSEcCtD
Tapentadol—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000168	0.000741	CcSEcCtD
Tapentadol—Urticaria—Prednisone—systemic lupus erythematosus	0.000168	0.000741	CcSEcCtD
Tapentadol—Headache—Triamcinolone—systemic lupus erythematosus	0.000168	0.000739	CcSEcCtD
Tapentadol—Headache—Methylprednisolone—systemic lupus erythematosus	0.000167	0.000737	CcSEcCtD
Tapentadol—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000166	0.000732	CcSEcCtD
Tapentadol—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000166	0.000732	CcSEcCtD
Tapentadol—Hypotension—Methotrexate—systemic lupus erythematosus	0.000165	0.000728	CcSEcCtD
Tapentadol—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000161	0.00071	CcSEcCtD
Tapentadol—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000161	0.000708	CcSEcCtD
Tapentadol—Dizziness—Betamethasone—systemic lupus erythematosus	0.000161	0.000708	CcSEcCtD
Tapentadol—Insomnia—Methotrexate—systemic lupus erythematosus	0.00016	0.000705	CcSEcCtD
Tapentadol—Nausea—Triamcinolone—systemic lupus erythematosus	0.000159	0.000701	CcSEcCtD
Tapentadol—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000159	0.0007	CcSEcCtD
Tapentadol—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000159	0.000699	CcSEcCtD
Tapentadol—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000158	0.000695	CcSEcCtD
Tapentadol—Somnolence—Methotrexate—systemic lupus erythematosus	0.000157	0.000693	CcSEcCtD
Tapentadol—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000156	0.000687	CcSEcCtD
Tapentadol—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000156	0.000686	CcSEcCtD
Tapentadol—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000154	0.000681	CcSEcCtD
Tapentadol—Vomiting—Betamethasone—systemic lupus erythematosus	0.000154	0.000681	CcSEcCtD
Tapentadol—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000154	0.000677	CcSEcCtD
Tapentadol—Rash—Dexamethasone—systemic lupus erythematosus	0.000153	0.000675	CcSEcCtD
Tapentadol—Rash—Betamethasone—systemic lupus erythematosus	0.000153	0.000675	CcSEcCtD
Tapentadol—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000153	0.000674	CcSEcCtD
Tapentadol—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000153	0.000674	CcSEcCtD
Tapentadol—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000153	0.000673	CcSEcCtD
Tapentadol—Fatigue—Methotrexate—systemic lupus erythematosus	0.000152	0.000672	CcSEcCtD
Tapentadol—Headache—Dexamethasone—systemic lupus erythematosus	0.000152	0.000671	CcSEcCtD
Tapentadol—Headache—Betamethasone—systemic lupus erythematosus	0.000152	0.000671	CcSEcCtD
Tapentadol—Asthenia—Prednisone—systemic lupus erythematosus	0.000152	0.000669	CcSEcCtD
Tapentadol—Pruritus—Prednisone—systemic lupus erythematosus	0.00015	0.00066	CcSEcCtD
Tapentadol—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000146	0.000642	CcSEcCtD
Tapentadol—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000145	0.000638	CcSEcCtD
Tapentadol—Nausea—Dexamethasone—systemic lupus erythematosus	0.000144	0.000636	CcSEcCtD
Tapentadol—Nausea—Betamethasone—systemic lupus erythematosus	0.000144	0.000636	CcSEcCtD
Tapentadol—Urticaria—Methotrexate—systemic lupus erythematosus	0.00014	0.000619	CcSEcCtD
Tapentadol—Dizziness—Prednisone—systemic lupus erythematosus	0.00014	0.000616	CcSEcCtD
Tapentadol—Vomiting—Prednisone—systemic lupus erythematosus	0.000134	0.000593	CcSEcCtD
Tapentadol—Rash—Prednisone—systemic lupus erythematosus	0.000133	0.000588	CcSEcCtD
Tapentadol—Dermatitis—Prednisone—systemic lupus erythematosus	0.000133	0.000587	CcSEcCtD
Tapentadol—Headache—Prednisone—systemic lupus erythematosus	0.000132	0.000584	CcSEcCtD
Tapentadol—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.00013	0.000574	CcSEcCtD
Tapentadol—Asthenia—Methotrexate—systemic lupus erythematosus	0.000127	0.000559	CcSEcCtD
Tapentadol—Nausea—Prednisone—systemic lupus erythematosus	0.000126	0.000554	CcSEcCtD
Tapentadol—Pruritus—Methotrexate—systemic lupus erythematosus	0.000125	0.000551	CcSEcCtD
Tapentadol—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000121	0.000533	CcSEcCtD
Tapentadol—Dizziness—Methotrexate—systemic lupus erythematosus	0.000117	0.000515	CcSEcCtD
Tapentadol—Vomiting—Methotrexate—systemic lupus erythematosus	0.000112	0.000495	CcSEcCtD
Tapentadol—Rash—Methotrexate—systemic lupus erythematosus	0.000111	0.000491	CcSEcCtD
Tapentadol—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000111	0.000491	CcSEcCtD
Tapentadol—Headache—Methotrexate—systemic lupus erythematosus	0.000111	0.000488	CcSEcCtD
Tapentadol—Nausea—Methotrexate—systemic lupus erythematosus	0.000105	0.000463	CcSEcCtD
Tapentadol—OPRM1—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	1e-05	0.00236	CbGpPWpGaD
Tapentadol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	9.89e-06	0.00233	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	9.87e-06	0.00233	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—CCR5—systemic lupus erythematosus	9.86e-06	0.00232	CbGpPWpGaD
Tapentadol—OPRM1—G alpha (i) signalling events—C3—systemic lupus erythematosus	9.63e-06	0.00227	CbGpPWpGaD
Tapentadol—UGT1A9—PPARA activates gene expression—EP300—systemic lupus erythematosus	9.59e-06	0.00226	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—TGFB1—systemic lupus erythematosus	9.57e-06	0.00226	CbGpPWpGaD
Tapentadol—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	9.39e-06	0.00221	CbGpPWpGaD
Tapentadol—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	9.29e-06	0.00219	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	9.27e-06	0.00219	CbGpPWpGaD
Tapentadol—HTR3A—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	9.22e-06	0.00217	CbGpPWpGaD
Tapentadol—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	9.15e-06	0.00216	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	9.07e-06	0.00214	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	9.06e-06	0.00214	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	8.96e-06	0.00211	CbGpPWpGaD
Tapentadol—OPRM1—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	8.93e-06	0.00211	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	8.79e-06	0.00207	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	8.71e-06	0.00205	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	8.65e-06	0.00204	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	8.32e-06	0.00196	CbGpPWpGaD
Tapentadol—UGT2B7—NRF2 pathway—TGFB1—systemic lupus erythematosus	8.18e-06	0.00193	CbGpPWpGaD
Tapentadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	8.09e-06	0.00191	CbGpPWpGaD
Tapentadol—SLC6A4—NRF2 pathway—TGFB1—systemic lupus erythematosus	8.05e-06	0.0019	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CCR5—systemic lupus erythematosus	8.05e-06	0.0019	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	7.96e-06	0.00188	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—C3—systemic lupus erythematosus	7.87e-06	0.00186	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	7.86e-06	0.00185	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	7.84e-06	0.00185	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	7.66e-06	0.00181	CbGpPWpGaD
Tapentadol—CYP2C19—Biological oxidations—RXRA—systemic lupus erythematosus	7.63e-06	0.0018	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	7.31e-06	0.00172	CbGpPWpGaD
Tapentadol—OPRM1—TCR Signaling Pathway—IL6—systemic lupus erythematosus	7.21e-06	0.0017	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—EP300—systemic lupus erythematosus	7.17e-06	0.00169	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	7.13e-06	0.00168	CbGpPWpGaD
Tapentadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	7.09e-06	0.00167	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CCR5—systemic lupus erythematosus	7.06e-06	0.00167	CbGpPWpGaD
Tapentadol—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	7.02e-06	0.00166	CbGpPWpGaD
Tapentadol—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	6.96e-06	0.00164	CbGpPWpGaD
Tapentadol—SLC6A2—NRF2 pathway—TGFB1—systemic lupus erythematosus	6.93e-06	0.00163	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—F2—systemic lupus erythematosus	6.91e-06	0.00163	CbGpPWpGaD
Tapentadol—SLC6A2—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	6.9e-06	0.00163	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—C3—systemic lupus erythematosus	6.9e-06	0.00163	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	6.72e-06	0.00159	CbGpPWpGaD
Tapentadol—UGT1A9—NRF2 pathway—TGFB1—systemic lupus erythematosus	6.65e-06	0.00157	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	6.64e-06	0.00157	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	6.64e-06	0.00157	CbGpPWpGaD
Tapentadol—HTR3A—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.53e-06	0.00154	CbGpPWpGaD
Tapentadol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	6.47e-06	0.00153	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.24e-06	0.00147	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	6.19e-06	0.00146	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	6.18e-06	0.00146	CbGpPWpGaD
Tapentadol—OPRD1—GPCR ligand binding—CCL2—systemic lupus erythematosus	6.16e-06	0.00145	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—NAT2—systemic lupus erythematosus	6.1e-06	0.00144	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—F2—systemic lupus erythematosus	6.06e-06	0.00143	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	6.03e-06	0.00142	CbGpPWpGaD
Tapentadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	5.99e-06	0.00141	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CCR5—systemic lupus erythematosus	5.97e-06	0.00141	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—C3—systemic lupus erythematosus	5.83e-06	0.00138	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	5.82e-06	0.00137	CbGpPWpGaD
Tapentadol—SLC6A4—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	5.76e-06	0.00136	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	5.62e-06	0.00133	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TLR9—systemic lupus erythematosus	5.47e-06	0.00129	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	5.43e-06	0.00128	CbGpPWpGaD
Tapentadol—OPRK1—GPCR ligand binding—CCL2—systemic lupus erythematosus	5.4e-06	0.00127	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—P2RY12—systemic lupus erythematosus	5.29e-06	0.00125	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	5.29e-06	0.00125	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—F2—systemic lupus erythematosus	5.12e-06	0.00121	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	5e-06	0.00118	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NAT2—systemic lupus erythematosus	4.95e-06	0.00117	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	4.93e-06	0.00116	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	4.92e-06	0.00116	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CSK—systemic lupus erythematosus	4.87e-06	0.00115	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	4.8e-06	0.00113	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TLR9—systemic lupus erythematosus	4.79e-06	0.00113	CbGpPWpGaD
Tapentadol—SLC6A4—Circadian rythm related genes—IL6—systemic lupus erythematosus	4.7e-06	0.00111	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—P2RY12—systemic lupus erythematosus	4.64e-06	0.00109	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	4.59e-06	0.00108	CbGpPWpGaD
Tapentadol—OPRM1—GPCR ligand binding—CCL2—systemic lupus erythematosus	4.56e-06	0.00108	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	4.55e-06	0.00107	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	4.48e-06	0.00106	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	4.47e-06	0.00105	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NCF2—systemic lupus erythematosus	4.46e-06	0.00105	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—C3—systemic lupus erythematosus	4.45e-06	0.00105	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—LYN—systemic lupus erythematosus	4.43e-06	0.00104	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.38e-06	0.00103	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—JAK1—systemic lupus erythematosus	4.36e-06	0.00103	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.34e-06	0.00102	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CSK—systemic lupus erythematosus	4.27e-06	0.00101	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	4.21e-06	0.000993	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	4.17e-06	0.000983	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCR5—systemic lupus erythematosus	4.13e-06	0.000975	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	4.07e-06	0.00096	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TLR9—systemic lupus erythematosus	4.05e-06	0.000955	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—C3—systemic lupus erythematosus	4.04e-06	0.000952	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	3.99e-06	0.000941	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.94e-06	0.000928	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.93e-06	0.000927	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—P2RY12—systemic lupus erythematosus	3.92e-06	0.000925	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NCF2—systemic lupus erythematosus	3.91e-06	0.000921	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—F2—systemic lupus erythematosus	3.9e-06	0.000921	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—C3—systemic lupus erythematosus	3.9e-06	0.00092	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—LYN—systemic lupus erythematosus	3.88e-06	0.000915	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.82e-06	0.000902	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.81e-06	0.000898	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.7e-06	0.000874	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.62e-06	0.000855	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CSK—systemic lupus erythematosus	3.61e-06	0.000851	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.57e-06	0.000842	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.56e-06	0.00084	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	3.56e-06	0.000839	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—F2—systemic lupus erythematosus	3.55e-06	0.000836	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—C3—systemic lupus erythematosus	3.54e-06	0.000835	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.54e-06	0.000835	CbGpPWpGaD
Tapentadol—SLC6A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.51e-06	0.000827	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—JUNB—systemic lupus erythematosus	3.5e-06	0.000824	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—F2—systemic lupus erythematosus	3.42e-06	0.000807	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—RXRA—systemic lupus erythematosus	3.42e-06	0.000806	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	3.37e-06	0.000795	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.32e-06	0.000784	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.32e-06	0.000783	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NCF2—systemic lupus erythematosus	3.3e-06	0.000779	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—C3—systemic lupus erythematosus	3.3e-06	0.000777	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—LYN—systemic lupus erythematosus	3.28e-06	0.000773	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.23e-06	0.000762	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—PRL—systemic lupus erythematosus	3.22e-06	0.00076	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.22e-06	0.000759	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—CCL2—systemic lupus erythematosus	3.16e-06	0.000745	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.12e-06	0.000737	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—F2—systemic lupus erythematosus	3.11e-06	0.000733	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.1e-06	0.00073	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—JUNB—systemic lupus erythematosus	3.07e-06	0.000723	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.06e-06	0.000722	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.02e-06	0.000712	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—C3—systemic lupus erythematosus	2.99e-06	0.000706	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.93e-06	0.000691	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.91e-06	0.000687	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—F2—systemic lupus erythematosus	2.89e-06	0.000682	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.87e-06	0.000677	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—PRL—systemic lupus erythematosus	2.82e-06	0.000666	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—RXRA—systemic lupus erythematosus	2.78e-06	0.000655	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.77e-06	0.000653	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.67e-06	0.00063	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.64e-06	0.000622	CbGpPWpGaD
Tapentadol—OPRD1—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.63e-06	0.00062	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—F2—systemic lupus erythematosus	2.63e-06	0.00062	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—JUNB—systemic lupus erythematosus	2.59e-06	0.000611	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—JAK1—systemic lupus erythematosus	2.58e-06	0.000608	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.58e-06	0.000607	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.52e-06	0.000593	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.46e-06	0.000581	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCR5—systemic lupus erythematosus	2.44e-06	0.000576	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.41e-06	0.000567	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL2—systemic lupus erythematosus	2.39e-06	0.000563	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—PRL—systemic lupus erythematosus	2.39e-06	0.000563	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—C3—systemic lupus erythematosus	2.39e-06	0.000563	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.34e-06	0.000552	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	2.33e-06	0.000549	CbGpPWpGaD
Tapentadol—OPRK1—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.31e-06	0.000544	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—JAK1—systemic lupus erythematosus	2.26e-06	0.000533	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PPARG—systemic lupus erythematosus	2.16e-06	0.000509	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	2.14e-06	0.000505	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCR5—systemic lupus erythematosus	2.14e-06	0.000505	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.13e-06	0.000501	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	2.12e-06	0.000501	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.11e-06	0.000497	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—F2—systemic lupus erythematosus	2.09e-06	0.000494	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL2—systemic lupus erythematosus	2.09e-06	0.000494	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—C3—systemic lupus erythematosus	2.09e-06	0.000493	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CD80—systemic lupus erythematosus	2.01e-06	0.000474	CbGpPWpGaD
Tapentadol—OPRM1—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.95e-06	0.00046	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—ALB—systemic lupus erythematosus	1.94e-06	0.000458	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.91e-06	0.00045	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.87e-06	0.00044	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—NOS3—systemic lupus erythematosus	1.86e-06	0.000438	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.85e-06	0.000436	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—F2—systemic lupus erythematosus	1.84e-06	0.000433	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.81e-06	0.000427	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.78e-06	0.00042	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.77e-06	0.000417	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—C3—systemic lupus erythematosus	1.77e-06	0.000417	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CD80—systemic lupus erythematosus	1.76e-06	0.000415	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PPARG—systemic lupus erythematosus	1.75e-06	0.000413	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—PTGS2—systemic lupus erythematosus	1.7e-06	0.0004	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.7e-06	0.0004	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.69e-06	0.000398	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.66e-06	0.000392	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.66e-06	0.000392	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.64e-06	0.000386	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—ALB—systemic lupus erythematosus	1.58e-06	0.000372	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—F2—systemic lupus erythematosus	1.55e-06	0.000366	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.52e-06	0.000358	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—NOS3—systemic lupus erythematosus	1.51e-06	0.000356	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CD80—systemic lupus erythematosus	1.49e-06	0.000351	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.49e-06	0.000351	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.46e-06	0.000344	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.46e-06	0.000343	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.44e-06	0.00034	CbGpPWpGaD
Tapentadol—UGT2B7—Metabolism—EP300—systemic lupus erythematosus	1.41e-06	0.000333	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL2—systemic lupus erythematosus	1.41e-06	0.000333	CbGpPWpGaD
Tapentadol—OPRD1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.4e-06	0.000331	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.38e-06	0.000326	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—PTGS2—systemic lupus erythematosus	1.38e-06	0.000325	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.33e-06	0.000315	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.33e-06	0.000314	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.33e-06	0.000313	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	1.31e-06	0.000308	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—EP300—systemic lupus erythematosus	1.27e-06	0.000298	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.26e-06	0.000298	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.26e-06	0.000296	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL2—systemic lupus erythematosus	1.24e-06	0.000292	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.23e-06	0.000291	CbGpPWpGaD
Tapentadol—OPRK1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.23e-06	0.00029	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.21e-06	0.000285	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	1.2e-06	0.000283	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.2e-06	0.000283	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	1.19e-06	0.000281	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—MMP9—systemic lupus erythematosus	1.17e-06	0.000276	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.17e-06	0.000275	CbGpPWpGaD
Tapentadol—UGT1A9—Metabolism—EP300—systemic lupus erythematosus	1.15e-06	0.000271	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—EP300—systemic lupus erythematosus	1.11e-06	0.000262	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.1e-06	0.00026	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.1e-06	0.000259	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.07e-06	0.000252	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.05e-06	0.000248	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL2—systemic lupus erythematosus	1.05e-06	0.000246	CbGpPWpGaD
Tapentadol—OPRM1—Signaling by GPCR—IL6—systemic lupus erythematosus	1.04e-06	0.000245	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—MMP9—systemic lupus erythematosus	9.89e-07	0.000233	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.86e-07	0.000232	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.65e-07	0.000228	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—EP300—systemic lupus erythematosus	9.38e-07	0.000221	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.88e-07	0.000209	CbGpPWpGaD
Tapentadol—OPRD1—Signaling Pathways—IL6—systemic lupus erythematosus	8.29e-07	0.000196	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	8.24e-07	0.000194	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—TGFB1—systemic lupus erythematosus	8.15e-07	0.000192	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	7.58e-07	0.000179	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	7.51e-07	0.000177	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	7.41e-07	0.000175	CbGpPWpGaD
Tapentadol—OPRK1—Signaling Pathways—IL6—systemic lupus erythematosus	7.27e-07	0.000171	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	7.09e-07	0.000167	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	6.82e-07	0.000161	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	6.76e-07	0.000159	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	6.52e-07	0.000154	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	6.48e-07	0.000153	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	6.46e-07	0.000152	CbGpPWpGaD
Tapentadol—OPRM1—Signaling Pathways—IL6—systemic lupus erythematosus	6.14e-07	0.000145	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	5.96e-07	0.000141	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	5.91e-07	0.000139	CbGpPWpGaD
Tapentadol—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	5.39e-07	0.000127	CbGpPWpGaD
Tapentadol—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	4.96e-07	0.000117	CbGpPWpGaD
Tapentadol—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	4.92e-07	0.000116	CbGpPWpGaD
